Small-Cap Stock Watch: Key Catalysts This Week (March 16–20)

From corporate updates to investor events, we’ve tracked the full scope of small-cap catalysts slated for the week ahead.

--

Material Events for This Upcoming Week

● ASBP — Will participate in The Health & Fitness (HFA) Show, scheduled for March 16–18, 2026, at the San Diego Convention Center. The company will feature its flagship caffeine product, BUZZ BOMB™, in the New Product Zone, highlighting its fast-acting, single-serving dry powder format designed for rapid caffeine delivery without water or mixing.

● BMR — Will demonstrate its ML-safe video compression technology for physical AI applications at GTC 2026, taking place March 16–19, 2026, with workshops beginning March 15. The presentation will focus on GPU-accelerated workflows for autonomous vehicles that can reduce video file sizes by up to 50% while maintaining machine learning model accuracy.

● ACON — CEO Brent Ness will attend LSI USA 2026 from March 16–20, 2026, where he is expected to meet with investors and potential industry partners to discuss progress advancing NOCISCAN, the company’s MR spectroscopy platform that uses AI and biomarkers to help identify painful versus non-painful discs in chronic low back pain patients.

● NYXH — Will participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference, held March 16–19, 2026. CEO Olivier Taelman is scheduled to deliver a corporate presentation on Monday, March 16, 2026, at 8:40 a.m. ET, and management will also be available for one-on-one meetings with institutional investors.

● MBOT — Will participate in the virtual Oppenheimer 36th Annual Healthcare MedTech & Services Conference from March 16–19, 2026. CEO Harel Gadot will present live on Thursday, March 19, 2026, at 8:40 a.m. ET, highlighting recent achievements from LIBERTY’s limited market release and the company’s strategy to drive adoption and long-term growth.

● GCTK — CEO Paul V. Goode, PhD, will present at LSI USA ’26 in Dana Point, California, taking place March 16–20, 2026. His presentation is scheduled for Tuesday, March 17, 2026, at 8:15 a.m. PT and will cover the company’s continuous blood glucose monitor technology, first-in-human results, regulatory path, and commercialization strategy.

● PROP — Interim CEO and President Rich Frommer and CFO Greg Patton will participate in Piper Sandler’s 26th Annual Energy Conference on March 16, 2026, where they will meet with investors in one-on-one settings.

● NSRX — Management will host a conference call and webcast on Monday, March 16, 2026, at 8:00 a.m. ET to present topline analysis from the Phase 2 repeated dose clinical study of NS002, the company’s intranasal powder epinephrine product candidate, followed by a Q&A session.

● BEAT — CEO Robert Eno and CFO Timothy Cruickshank will attend the virtual Oppenheimer 36th Annual Healthcare MedTech & Services Conference on March 16–17, 2026. Management will host a presentation webcast on March 16, 2026, at 11:20 a.m. ET and also conduct one-on-one meetings with institutional and retail investors.

● CLAR — The board confirmed a regular quarterly cash dividend of $0.025 per share, payable on March 25, 2026, to stockholders of record as of March 16, 2026.

● NTIP — The board declared a semi-annual cash dividend of $0.05 per common share, payable on March 30, 2026, to stockholders of record as of March 16, 2026.

● LAES — SEALSQ will actively engage in the Connectivity Standards Alliance Member Meeting in Yokohama from March 16–19, 2026.

● TOI — Will present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference on Monday, March 16, 2026, from 10:00 a.m. to 10:30 a.m. ET in a virtual format. Presenters will be CEO Dr. Daniel Virnich and CFO Rob Carter.

● TRAW — Reported that the FDA intends to formally communicate its concerns and suggested mitigation steps regarding the company’s tivoxavir marboxil IND by March 16, 2026, after placing the U.S. IND on clinical hold due to concerns with the mutagenicity data package.

● DEFT — DeFi Technologies and Valour, in partnership with MERGE, will host the DeFi Technologies Insights Symposium in São Paulo on March 16, 2026. The broader program also includes an invitation-only institutional gathering on March 17 and the main MERGE conference at WTC São Paulo from March 18–19, 2026.

● ALDX — Announced that the FDA extended the PDUFA target action date for the reproxalap NDA for dry eye disease to March 16, 2026.

● FTCI — Will participate in the UBS Global Energy and Utilities Conference in London on March 17, 2026, where the company will host in-person investor meetings.

● BIVI — Announced acceptance of an abstract from its SUNRISE-PD study on bezisterim (NE3107) for presentation at AD/PD 2026, taking place March 17–21, 2026, in Copenhagen, Denmark.

● GANX — Will present at the AD/PD 2026 International Conference on Alzheimer’s and Parkinson’s Disease and Related Neurological Disorders, held March 17–21, 2026, in Copenhagen, Denmark, and also provided an update regarding its IND application for a planned Phase 2 clinical trial of GT-02287 in Parkinson’s disease.

● CRVO — Will be featured in both an oral presentation and a scientific symposium at AD/PD 2026 in Copenhagen, Denmark, from March 17–21, 2026. The presentations will include secondary analyses from the Phase 2b RewinD-LB trial supporting the planned Phase 3 program in dementia with Lewy bodies.

● ULCC — CEO Jimmy Dempsey will participate in a moderated discussion hosted by Jamie Baker at the J.P. Morgan 2026 Industrials Conference on Tuesday, March 17, 2026, at 9:30 a.m. EDT.

● AMIX — CEO Brad Hauser will present at LSI USA ’26 on Tuesday, March 17, 2026, at 9:15 a.m. PT. Management will also be available for in-person one-on-one meetings with qualified investors attending the conference.

● RPID — Will participate in the KeyBanc Capital Markets Healthcare Forum and is scheduled for a virtual Q&A session with the host analyst on Tuesday, March 17, 2026, at 11:15 a.m. ET.

● AVX — Will participate in the Digital Chamber’s DC Blockchain Summit 2026, taking place March 17–18, 2026, in Washington, D.C.

● DTIL — Will host a virtual key opinion leader event on Tuesday, March 17, 2026, at 9:00 a.m. ET to discuss PBGENE-DMD and the planned Phase 1/2 FUNCTION-DMD clinical study.

● CAMP — Will deliver a corporate presentation at the Stifel CNS Forum on March 17, 2026, at 10:00 a.m. ET in a virtual format.

● ACIU — Will host an industry symposium on a precision prevention approach to Parkinson’s disease and will also present its first-in-class TDP-43 PET-tracer at AD/PD 2026 in Copenhagen, Denmark, from March 17–21, 2026.

● LFMD — Will participate in the KeyBanc Capital Markets Healthcare Forum on March 17–18, 2026. Management is scheduled for a virtual fireside chat on Wednesday, March 18, 2026, at 9:00 a.m. ET, a virtual panel at 12:00 p.m. ET, and one-on-one virtual meetings.

● XGN — Will participate in the KeyBanc Capital Markets Healthcare Forum on March 17, 2026, including investor meetings and a fireside chat at 3:00 p.m. ET.

● VTGN — Will participate in the Stifel 2026 Virtual CNS Forum on March 17, 2026, with a fireside chat featuring President and CEO Shawn Singh at 9:00 a.m. EDT, along with one-on-one meetings.

● ANVS — Will present two sessions at AD/PD 2026 in Copenhagen, Denmark, from March 17–21, 2026, highlighting clinical data on buntanetap in Parkinson’s disease and an update on the ongoing pivotal Phase 3 trial in early Alzheimer’s disease.

● ABOS — Management will participate in a fireside chat at the Stifel 2026 Virtual CNS Forum on Wednesday, March 18, 2026, at 11:00 a.m. ET.

● IMUX — Will participate in the Stifel 2026 Virtual CNS Forum on March 17–18, 2026, with a fireside chat scheduled for Wednesday, March 18, 2026, at 4:00 p.m. ET.

● LIDR — CEO Matt Fisch and CFO Conor Tierney will participate in Bank of America’s 2026 Global Automotive Summit in New York from March 17–18, 2026, where they will engage in one-on-one and small group meetings with institutional investors.

● EVH — Will participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference, held virtually on March 17, 2026.

● TALK — Will participate in the virtual KeyBanc Capital Markets Healthcare Forum, including one-on-one meetings and a fireside chat on Tuesday, March 17, 2026, at 2:15 p.m. ET.

● CYH — Will participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference, held virtually from March 16–19, 2026, with a presentation scheduled for Tuesday, March 17, 2026, at 11:20 a.m. ET.

● RXRX — Will be featured in HighRes’ Lightning Talk at the NVIDIA GTC AI Conference & Expo, taking place March 16–19, 2026, in San Jose, with a session focused on AI agents, robotics, digital twins, and self-driving labs in drug discovery and biomanufacturing.

● ABSI — Will participate in the KeyBanc Capital Markets Healthcare Forum with a fireside chat on Tuesday, March 17, 2026, at 1:30 p.m. ET / 10:30 a.m. PT, and will also host one-on-one meetings.

● ABCL — Will participate in the KeyBanc Capital Markets Healthcare Forum on March 17, 2026.

● ELBM — VP, Commercial Michael Insulan will present at the 13th Tokyo Battery Summit – Critical Minerals & Economic Security on March 17–18, 2026, in a forum focused on North American resource policy, economic security, and supply-chain resilience across battery materials, rare earths, and recycling.

● XAIR — Announced that the original submitted abstract titles and text for its Phase 1 intratumoral UNO data selected for presentation at AACR 2026 will be published in the AACR Online Itinerary Planner on March 17, 2026, at 4:30 p.m. ET / 1:30 p.m. PT.

● DHX — Management will participate in the Sidoti Small Cap Conference, held virtually on March 18–19, 2026. CEO Art Zeile and CFO Greg Schippers are scheduled to present on March 19, 2026, at 12:15 p.m. ET and will also host one-on-one meetings.

● FRMM — Chairman and CEO McAndrew Rudisill and SVP John Kristoff are expected to participate in the Sidoti Small-Cap Virtual Investor Conference on Wednesday, March 18, 2026.

● ALIT — Will participate in the KeyBanc Capital Markets Healthcare Forum on Wednesday, March 18, 2026, in a virtual format, including a fireside chat at 11:15 a.m. ET and one-on-one meetings.

● FMST — Will host a RedChip investor webinar on March 18, 2026, at 4:15 p.m. ET, featuring an overview of its uranium exploration portfolio and strategy in Saskatchewan’s Athabasca Basin.

● TUYA — The board approved a cash dividend of US$0.0605 per ordinary share, or ADS, payable to holders of record as of the close of business on March 18, 2026, Hong Kong Time and New York Time, respectively.

● HOVR — Will participate in the Quebec Air Transport Association 2026 Convention from March 18–20, 2026, in Montréal, where the company will join a live panel discussion and be available for informal conversations.

● TKNO — Will participate in the KeyBanc Capital Markets Healthcare Forum on Wednesday, March 18, 2026, at 11:15 a.m. ET and in the Sidoti Small Cap Conference on Thursday, March 19, 2026, at 1:00 p.m. ET.

● ANNX — Will host an in-person and virtual key opinion leader event in New York on Wednesday, March 18, 2026, with presentations at 2:00 p.m. ET and a reception at 4:00 p.m. ET, focused on geographic atrophy, C1q biology, vonaprument, and the ARCHER II Phase 3 trial.

● VYGR — Will participate in Stifel 2026 CNS Days with a fireside chat on Wednesday, March 18, 2026.

● INO — Will present at the Eurogin HPV Conference in Vienna, Austria, on Thursday, March 19, 2026, at 8:00 a.m. CET, with a presentation on long-term surgical intervention reduction in HPV-6 and 11 recurrent respiratory papillomatosis.

● WTI — The board approved and declared a quarterly cash dividend of $0.01 per share, payable on March 26, 2026, to stockholders of record on March 19, 2026.

● UIS — Will present research on commercial applications of quantum computing at the American Physical Society’s Global Physics Summit, which begins March 15, 2026. On March 18, 2026, senior quantum engineer Arati Sahoo will present virtually on enhancing intrusion detection systems through generative dataset balancing with quantum Boltzmann machines.

● ACCO — The board declared a quarterly cash dividend of $0.075 per share, payable on March 26, 2026, to stockholders of record as of the close of business on March 20, 2026.

--

Disclaimer: All content provided by BigTimePennys Report is for informational purposes only. The information provided should not be considered as a substitute for professional advice, analysis, or guidance. Any investment decisions made based on the information provided are solely at the user's own risk. BigTimePennys Report are not liable for any losses or damages incurred as a result of using this information. BigTimePenny is not operated by a licensed broker, a dealer, or a registered investment adviser. The Securities Litigation Reform Act of 1995 provides safe harbor protection for forward-looking statements made by companies or individuals. It should be noted that any forward-looking statements made by BigTimePennys Report, its authors, are not guarantees of future performance or results. These statements are subject to risks, uncertainties, and assumptions that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. The content provided by BigTimePennys Report does not constitute an endorsement, recommendation, or solicitation to buy, sell, or hold any securities or investment products. BigTimePennys Report, its authors, do not endorse or recommend any specific investment strategies, securities, or companies. It is crucial to conduct thorough research and seek advice from a qualified professional before making any investment decisions. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. The user assumes full responsibility for the use of the information provided by BigTimePennys Report. BigTimePennys Report, its authors, disclaim any liability for any direct, indirect, or consequential damages arising from the use or reliance on the information provided. Users should exercise their own judgment and discretion when interpreting and utilizing the information provided. Please note that the content provided by BigTimePennys Report is based on available information and sources believed to be reliable. However, market conditions and regulations may change over time, and there may be inaccuracies or errors in the information provided. It is recommended to verify the information with current and reliable sources before making any investment decisions. Investing in micro-cap companies is highly speculative and carries an extremely high degree of risk. BigTimePenny is not a fiduciary by virtue of any person's use of or access to this content. We were NOT compensated for this article.